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Triggering of Natural Killer Cells
by the Costimulatory Molecule CD80 (B7-1)
Benedict J. Chambers, Margarita Salcedo, cells are normally CD28 negative. However, a human
CD281 NK cell leukemia YT2C2 cell line (or variants ofand Hans-Gustaf Ljunggren
Microbiology and Tumor Biology Center this line) spontaneously lysed human as well as mouse
cell lines expressing B7-1 (Azuma et al., 1992; MontelKarolinska Institute
S-171 77 Stockholm et al., 1995a). Furthermore, rejection responses against
murine B7-1–transfected tumor cell lines were likely toSweden
involve an NK cell component (Cavallo et al., 1995; Geld-
hof et al., 1995; Wu et al., 1995; Yeh et al., 1995), and
in two of these studies the B7-1-transfected tumor cellSummary
lines examined were killed by splenocytes in vitro at
higher levels than corresponding wild-type cell linesNK cell–mediated cytotoxicity is influenced by trig-
(Geldhof et al., 1995; Yeh et al., 1995). An additionalgering as well as inhibitory signals. The identifica-
potential connection between B7-1 and NK cells is sug-tion of inhibitory signals provided by MHC class I mol-
gested by the observation that poly I:C–activated splen-ecules has recently attracted significant attention.
ocytes could suppress antigen-presenting cells (APC)Much less is known about putative triggering signals.
in mixed lymphocyte cultures (Gilbertson et al., 1986).Using purified populations of mouse NK cells, we dem-
In the present study, we have directly addressed theonstrate that the CD80 (B7-1) gene product functions
ability of the costimulatory molecule B7-1 to trigger NKas a triggering signal for NK cell–mediated cytotoxic-
cell–mediated lysis. We demonstrate that MHC classity. The strength of this response is such that it over-
I–positive NK cell–resistant targets become sensitive torides the protection mediated by MHC class I mole-
NK cells after transfection of B7-1. These results suggestcules. Triggering of mouse NK cells by B7-1 occurred
that the costimulatory molecule B7-1 functions as a trig-even in the absence of CD28 and could not be blocked
gering molecule for NK cell–mediated cytotoxicity inby either anti-CD28 or anti-CTLA-4 antibodies. NK
vitro and that the strength of this triggering response iscells may thus, at least in part, use receptors other
such that it overrides the MHC class I–mediated protec-than CD28 and CTLA-4 in their interaction with B7-1.
tion against NK cell–mediated lysis. In addition, acti-Furthermore, we demonstrate that bone marrow–
vated macrophages and dendritic cells, characterizedderived macrophages and dendritic cells are highly
by their expression of costimulatory molecules, weresusceptible to lysis by autologous NK cells.
highly susceptible to NK cell–mediated lysis. Triggering
of mouse NK cells by B7-1-transfected tumor cell linesIntroduction
and by activated APC occurred even in the absence of
CD28 and could not be blocked by anti-CD28 andNatural killer (NK) cell–mediated cytotoxicity is influ-
CTLA-4 antibodies. These data are discussed in relationenced by triggering as well as inhibitory signals (Gum-
to events involved in the triggering and inhibition of NKperz and Parham, 1995; Lanier and Philips, 1996; Raulet,
cell–mediated lysis.1996). Recent studies have demonstrated that target
cell major histocompatibility complex (MHC) class I mol-
Resultsecules can turn off NK cells (Ljunggren and Ka¨rre, 1990;
Ka¨rre, 1995), by delivering a negative signal to specific
Purified NK Cells Are Triggered by B7-1-ExpressingMHC class I–binding receptors (Karlhofer et al., 1992;
Tumor Cell LinesYokoyama and Seaman, 1993). The latter include mem-
C57BL/6 (B6)-derived lymphokine-activated killer (LAK)bers of the Ly-49 gene family in mouse and the killer cell
cells or Tilorone-activated splenocytes do not efficientlyinhibitor receptor (KIR) gene family in humans (Gumperz
kill MHC class I–positive EL-4 cells. In contrast, similarand Parham, 1995; Lanier and Philips, 1996; Raulet,
effector cells readily killed EL-4 cells transfected with1996). On the other hand, triggering receptors, such as
B7-1 (EL-4 B7-1), while sparing vector-transfected ormembers of the NKR-P1 family (Yokoyama and Seaman,
untransfected control cells (Figure 1A; data not shown).1993), may receive stimulatory signals from as yet un-
These results were not a specific property of B7-1-identified ligands. The general notion holds that NK cells
transfected EL-4 cells. The MHC class I–positive RMAmust be triggered by any of a set of distinct target cell
B7-1 and P815 B7-1 cell lines, respectively, were alsoligands, but that all of these signals can be overruled
highly sensitive to LAK cell lysis, while nontransfectedby MHC class I–mediated inhibition (e.g., see Correa et
wild-type cells were resistant to lysis (Figure 1B; dataal., 1994).
not shown for P815 B7-1). The lysis of EL-4 B7-1 andThe CD80 (B7-1) gene product, and its counterrecep-
RMA B7-1 could be inhibited by addition of CTLA-4Ig,tors CD28 and CTLA-4, have been extensively charac-
demonstrating that B7-1 was the triggering signal forterized in recent years in their delivery of costimulatory
target cell lysis and that the effect was not an indirectsignals to naive T cells (Linsley and Ledbetter, 1993;
consequence of B7-1 expression (Figure 2).Allison, 1994; Sharpe, 1995). B7-1 is expressed at high
levels on hematopoietic cells such as activated macro- It was important to verify that the effector cells within
the LAK population, triggered by B7-1 expression onphages and dendritic cells. Recent studies have indi-
cated that NK cells may be affected, indirectly or di- the tumor cell lines, fulfilled the criteria of being pheno-
typically normal NK cells. It was also important to assessrectly, by costimulatory molecules. Human adult NK
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Figure 2. Lysis of EL-4 and RMA Tumor Cells Transfected with B7-1
Figure 1. LAK Cell Lysis of MHC Class I–Positive and MHC Class Is Inhibited by CTLA-4Ig
I–Deficient Tumor Cell Lines Transfected with B7-1 (A) Target cells were as follows: EL-4 (open circles), EL-4 B7-1
(A) Target cells were as follows: EL-4 (open circles), EL-4 B7-1 (closed circles), and EL4-4 B7-1 and CTLA-4Ig (closed squares).
(closed circles), and C4.4-252 (b2m2 variant of EL-4; open squares). (B) Target cells were as follows: RMA (open diamonds), RMA B7-1
(B) Target cells were as follows: RMA (open diamonds), RMA B7-1 (closed diamonds), and RMA B7-1 and CTLA-4Ig (closed squares).
(closed diamonds), RMA-S (TAP22 variant of RMA; open triangles),
and RMA-S B7-1 (closed triangles).
class I expression (Ljunggren and Ka¨rre, 1985; Ka¨rre et
al., 1986). Transfection of the B7-1 gene into these cell
lines did not alter their levels of MHC class I expressionwhether triggering by B7-1 was a property of a subpopu-
as determined by FACS analysis (data not shown). Thelation of NK cells or a more general property of all NK
ability of NK cells to kill B7-1-transfected EL-4 and RMAcells. Since the LAK cell cultures could be a potential
cells demonstrated that the protection mediated bysource of cytotoxic T cells activated by IL-2, we first
MHC class I expression could be overridden by thesorted the LAK cell cultures into NK1.11 and CD81 popu-
expression of B7-1. Indeed, B7-1-transfected EL-4 andlations. All cytotoxic activity toward EL-4 B7-1 resided in
RMA cells were rendered as sensitive to NK cell–the NK1.11 population of the LAK cells (Table 1). Similar
mediated lysis as MHC class I–deficient variants of theeffectors also preferentially killed the MHC class I–defi-
EL-4 and RMA cell lines, respectively (Figure 1).cient EL-4 subline C4.4-252 as well as the standard NK
Transfecting MHC class I–deficient RMA-S cells with
target cell line YAC-1 (Table 1). A theoretical possibility
B7-1 further potentiated the NK sensitivity of this cell
was that all killing of B7-1-transfected target cells was
line (Figure 1). This indicated that, even though the ex-
mediated by a small fraction of NK1.11 T cells. We there- pression of B7-1 could override the protection imposed
fore sorted out NK1.11 TCRab2 effectors. The NK1.11/ by MHC class I expression, MHC class I molecules were
TCRab2 population was found to lyse EL-4 B7-1, but still able to offer some degree of protection (Figure 1).
not EL-4 (data not shown). We then further subfractio- In the studies of the NK cell subpopulations, we ob-
nated the NK1.11 population of LAK cells into NK1.11/ served that the EL-4 as well as EL-4 B7-1 cell lines were
Ly-49A1, NK1.11/Ly-49A-, NK1.11/Ly-49C1, and NK1.11/ killed at slightly reduced levels by NK1.11/Ly-49C1 cells
Ly-49C- subpopulations. All four subpopulations of NK compared with the levels of lysis observed for the
cells preferentially killed the B7-1-transfected EL-4 tar- NK1.11/Ly-49C2 subpopulation (Figure 3). This result is
get cells over control EL-4 cells (Figure 3), indicating interesting in relation to the notion of Ly-49C being an
that the triggering of NK cells by B7-1 might be a more inhibitory receptor for H-2Kb (Yu et al., 1996), since it
general property of NK cells. provides additional support for the idea that B7-1 is able
to override the protection mediated by MHC class I
NK Cell Triggering by B7-1 Overrides the Protection expression. However, on the other hand, it also indicates
Mediated by MHC Class I Molecules that MHC class I molecules can confer some level of
EL-4 and RMA cells are normally protected from NK cell protection from NK cell–mediated lysis despite B7-1
expression on the target cell.lysis by virtue of their high constitutive levels of MHC
Table 1. NK1.11 LAK Cells Kill B7-1-Transfected EL-4 Cells
NK1.11 LAK CD81 LAK
Effector: Target Ratio EL-4 EL-4 B7-1 C4.4-252 YAC-1 EL-4 EL-4 B7-1 C4.4-252 YAC-1
30:1 10 46 33 77 0 2 0 12
10:1 0 42 15 51 0 0 0 11
3:1 0 35 12 33 0 0 0 4
1:1 0 22 5 22 0 1 0 3
C4.4-252 is a b2m2 mutant of EL-4. Results are expressed as percent specific lysis.
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Figure 3. Lysis of EL-4 B7-1 Cells Is a Prop-
erty of Several Defined Subsets of NK1.11
Cells
NK1.11 effectors were purified from LAK cell
cultures and further subfractionated into
NK1.11/Ly-491, NK1.11/Ly-49A2, NK1.11/Ly-
49C1, and NK1.11/Ly-49C2 populations. Tar-
get cells were EL-4 (open circles) and EL-4
B7-1 (closed circles).
NK Cell–Mediated Killing of B7-1-Transfected Tumor clone can be mediated by Fas–FasL interactions (Montel
et al., 1995b; Roger et al., 1996). In contrast, NK cell–Cell Lines Occurs in the Absence of CD28
and Cannot Be Blocked by Antibodies mediated cytotoxicity in the mouse has been demon-
strated tobe dependent on perforin (Ka¨gi et al., 1994). Toagainst CD28 and CTLA-4
Recognition of B7-1 by T cells is mediated by the recep- address whether mouse NK cells can use the Fas–FasL
pathway, or pathways other than perforin-mediated kill-tors CD28 and CTLA-4 (Linsley and Ledbetter, 1993;
Allison, 1994; Sharpe, 1995). To address the role of CD28 ing, upon interaction with B7-1-transfected targets, we
prepared LAK cells from perforin2/2 mice. When suchon NK cells with respect to the triggering effects im-
posed by B7-1 expressed on tumor targets, we gener- effectors were used, all killing capacity was abolished,
strongly suggesting that the triggering of NK cells byated LAK effectors from CD282/2 mice. Effector cells
from such mice killed EL-4 B7-1 targets at a level equiva- B7-1 in the mouse leads to cytotoxicity mediated by
perforin (Table 2).lent to effectors from wild-type (B6) mice (Table 2). Al-
though this result did not exclude a role for CD28 on
NKcells from wild-type mice, it suggested that receptors NK Cells Lyse Bone Marrow–Derived
Macrophages and Dendritic Cellsother than CD28 on NK cells might be capable of inter-
acting with B7-1. To address further the role of CD28, NK cell–mediated recognition of target cells expressing
costimulatory molecules such as B7-1 implies that cellsas well as that of CTLA-4, in B7-1 recognition by NK
cells, we preincubated LAK cells from B6 mice with anti- normally expressing such molecules, e.g., activated
APC, may be targeted by NK cells. Indeed, autologousCD28 or anti-CTLA-4 antibodies (0.4–50 mg/ml). These
experiments did not reveal any significant effects by bone marrow–derived macrophages as well as dendritic
cells were found to be highly susceptible to LAK cell–either anti-CD28 or anti-CTLA-4 antibodies on the rec-
ognition of B7-11 targets (data not shown). Interestingly, mediated lysis (Figure 4). In contrast with the results
obtained with the macrophages or dendritic cell prepa-these results indicate that NK cells may use receptors
other than CD28 and CTLA-4 in interactions with B7-1 rations, autologous concanavalin A (ConA)-activated T
cell blasts were resistant to LAK cells. In contrast withmolecules.
bone marrow–derived macrophages, resting peritoneal
macrophages were not lysed by similar LAK cells (dataNK Cell–Mediated Killing of B7-1-Expressing
Targets Is Perforin Dependent not shown). Macrophages and dendritic cells from MHC
class I–deficient mice were found to be killed even moreStudies of the human leukemic NK cell line YT2C2 (or
variants of it) have suggested that cytotoxicity by this efficiently than similar cells from wild-type mice (Figure
Table 2. LAK Cell Lysis of EL-4 B7-1 Is Perforin Dependent, but Does Not Require CD28
EL-4 EL-4 B7-1 YAC-1
Effector: Target Ratio B6 CD282/2 Perforin2/2 B6 CD282/2 Perforin2/2 B6 CD282/2 Perforin2/2
Experiment 1
100:1 27 24 0 67 56 1 56 65 4
33:1 21 22 0 58 49 1 50 46 4
11:1 20 11 0 56 41 0 48 39 3
3:1 13 8 0 46 23 0 32 18 1
Experiment 2
100:1 11 9 0 37 34 3 70 72 9
33:1 9 6 0 38 30 0 64 61 8
11:1 3 4 0 34 25 0 62 62 11
3:1 1 2 0 27 17 1 45 48 13
Results are expressed as percent specific lysis.
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Figure 4. Bone Marrow–Derived Macrophages and Dendritic Cells
Are Susceptible to LAK Cell Lysis Figure 5. Lysis of Bone Marrow–Derived Macrophages and Den-
Bone marrow–derived macrophages and dendritic cells, as well as dritic Cells Is a Property of NK1.11 Cells
control ConA-activated T cell blasts, were tested for susceptibility LAK effectors were sorted into NK1.11 and CD81 populations and
to LAK cell–mediated lysis. used as effectors against bone marrow–derived macrophages (open
(A) Target cells were as follows: bone marrow–derived macrophages diamonds) and dendritic cells (open circles), as well as ConA-acti-
(open diamonds) and dendritic cells (open circles), as well as ConA- vated T cell blasts (open squares) from B6 mice.
activated T cell blasts from B6 mice (open squares).
(B) Target cells were as follows: bone marrow–derived dendritic
cells from B6 (open circles) and b2m2/2 mice (closed circles), as
NK cell–mediated lysis despite expression of MHC classwell as ConA-activated T cell blasts from B6 (open squares) and
I molecules.b2m2/2 mice (closed squares).
The general belief holds that NK cell–mediated cyto-
toxicity is controlled by positive as well as negative
signals. While the latter have attracted much attention4; data not shown), analogous to MHC class I–deficient
B7-1-transfected tumor cell lines (Figure 1). during the last years, significantly less is known about
the former (Raulet, 1996). The present data strongly sug-As with B7-1-transfected tumor targets, all cytotoxic-
ity against the bone marrow–derived macrophages and gest that costimulatory molecules, such as B7-1, may
fall into the category of NK cell–triggering molecules.dendritic cells resided in the NK1.11 population of LAK
cells (Figure 5). Blocking studies with CTLA-4Ig failed to The consensus has been that the negative signal pro-
vided by MHC class I molecules dominates over trig-block completely the killing of the bone marrow–derived
macrophages or dendritic cells (data not shown). This gering signals (e.g., see Correa et al., 1994). The present
results suggest that some triggering responses readilyobservation indicates that molecules on these cells
other than B7-1 and B7-2 may be involved in NK cell override the inhibitory signals provided by MHC class I
molecules. We propose that the final outcome of NKtriggering, yet the results do not exclude a role for B7-1,
B7-2, or both. LAK cell–mediated lysis of both macro- cell–mediated cytotoxicity is a result of the interaction
between triggering and inhibitory ligands and receptors,phages and dendritic cells did not require CD28, as
demonstrated using LAK cells from CD282/2 mice. As respectively, and that the net result of these interactions
will determine the susceptibility to lysis. In the presentobserved for B7-1-transfected tumor cell lines, LAK cell
lysis of the macrophages and dendritic cells could not model, focusing on the interplay between one triggering
(B7-1) and one inhibitory (MHC class I) ligand, target cellbe blocked by antibodies against CD28 or CTLA-4 (data
not shown). All killing of the bone marrow–derived mac- susceptibility varies according to the following equation,
with the most NK-resistant cells mentioned first: MHCrophages and dendritic cells appeared to be mediated
through the perforin pathway, since LAK cells from class I1/B7-12 < MHC class I2/B7-12 5 MHC class I1/
B7-11 < MHC class I2/B7-11.perforin2/2 mice didnot lyse these cells (data not shown).
The present results indicate that the expression of
B7-1 on tumor cells per se triggers NK cells and thatDiscussion
this is not the consequence of indirect events, such as
concomitant down-regulation of MHC class I. The NKUsing purified populations of mouse NK cells, we dem-
onstrate that the B7-1 gene product functions as a trig- cell–triggering ligands on mouse bone marrow–derived
macrophages and dendritic cells are unknown. How-gering signal for NK cell–mediated cytotoxicity. The
strength of the triggering response is such that it over- ever, since they do express significant levels of costimu-
latory molecules such as B7-1 and B7-2 (Linsley andrides the protection mediated by MHC class I molecules.
Triggering of NK cells by B7-1-transfected target cells Ledbetter, 1993; Allison, 1994; Sharpe, 1995), it is tempt-
ing to speculate that these molecules may contributeappears not to be dependent on the CD28 or CTLA-4
receptors. In addition to B7-1-transfected tumor cell to some extent to the NK cell–sensitive phenotype. Lysis
of both B7-11 tumors and APC required perforin, sug-lines, we demonstrate that bone marrow–derived mac-
rophages and dendritic cells are highly susceptible to gesting that Fas–FasL interactions would have no role,
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[b2m2]) variant of EL-4 (Glas et al., 1992). RMA is a variant of theor only a minor role, in these types of cytotoxic re-
Rauscher virus–induced T cell lymphoma RBL-5 of B6 background.sponses. This differs from results with the human YT2C2
RMA-S is an MHC class I–deficient (TAP2-deficient) variant of RMAcell line, in which the Fas–FasL pathway contributed, at
(Ljunggren and Ka¨rre, 1985). YAC-1 is a highly NK cell–sensitive
least in part, to the lytic activity (Montel et al., 1995b). Moloney virus–induced T cell lymphoma of A/Sn background. P815
T lymphocyte recognition of B7-1 leads to either T is a mastocytoma of DBA/2 background. EL-4 cells transfected with
vectors containing the murine B7-1 gene (Chen et al., 1994) andcell activation or inhibition depending on whether the
vector control cells were provided by Drs. T. Wen and I. Hellstro¨m.interaction is mediated by CD28 or CTLA-4 (Linsley and
B7-1 transfectants of RMA, RMA-S, and P815 (designated RMALedbetter, 1993; Allison, 1994; Sharpe, 1995; Tivol et al.,
B7-1, RMA-S B7-1, and P815 B7-1, respectively) were generated
1995; Waterhouse et al., 1995). We have shown that by electroporation using a B7-1 construct in a pBR322 plasmid (a
B7-1 molecules trigger NK cell cytotoxicity. However, gift to Dr. K. Ka¨rre from Dr. G. J. Freeman, Dana–Farber Cancer
B7-1 molecules may impose other effects on NK cells Institute and Harvard Medical School, Boston, MA). All cells, includ-
ing vector controls, were screened on a regular basis for B7-1 ex-as well, including the induction of NK cell proliferation
pression by flow cytometry with the biotinylated anti-CD80 (B7-1)and cytokine secretion (Nandi et al., 1994). Our results
monoclonal antibody 16-10A1 (Pharmingen, San Diego, CA) andfurther indicate that the receptors onNK cells that recog- Neutralite avidin–FITC (Southern Biotechnology Associates, Bir-
nize B7-1 may be different from CD28 and CTLA-4, or mingham, AL). For blocking studies, hamster anti-CTLA-4 (UC10-
at least not restricted to these receptors. This contrasts 4F10-11) and anti-CD28 (37.51) were used (both from Pharmingen).
The CTLA-4Ig fusion protein was provided originally by Dr. P. Lanewith the results obtained with the human NK cell leuke-
(Basel Institute for Immunology, Basel, Switzerland). For fluores-mia YT2C2 line, where B7-1 triggering was mediated
cence-activated cell sorter (FACS) analysis of the effector popula-through interactions with CD28 (Azuma et al., 1992;
tions, biotin-conjugated anti-Ly-49A (A1), anti-TCRab (H57-597),
Montel et al., 1995a). The physiological significance of anti-CD8 (53-6.7), FITC-conjugated anti-Ly-49C (SW5E6), and PE-
the latter findings is less clear, however, because adult conjugated anti-NK1.1 (PK136) were used (all from Pharmingen).
For assessment of MHC class I expression, FITC-conjugated anti-human NK cells are CD28 negative.
H-2Kb (AF6-88.5) and anti-H-2Db (KH95) were used (both from Phar-The transfection of B7-1 into tumor cell lines has be-
mingen).come an attractive means for anti-tumor immunotherapy
to induce strong anti-tumor cytotoxic T cells. It is be- Mice
lieved that B7-1-expressing tumor cells may function B6 mice were from B&K Universal AB (Sollentuna, Sweden) and
from the Microbiology and Tumor Biology Center of the Karolinskadirectly as professional APC, being capable of activating
Institute (Stockholm, Sweden). b2m2/2 (Koller et al., 1990), CD282/2naive T cells. The present data, as well as previous
(Shahinian et al., 1993), and perforin2/2 (Ka¨gi et al., 1994) mice havefindings (Cavallo et al., 1995; Geldhof et al., 1995; Wu et
been described previously. All mice were maintained at the Microbi-
al., 1995; Yeh et al., 1995), suggest that B7-1-transfected ology and Tumor Biology Center of the Karolinska Institute. The
tumor cells may serve as targets for NK cells. These mutant mice were gifts of Drs. B. H. Koller, T. W. Mak, and H.
observations have led to a reinterpretation of the role of Hengartner. Animal care was in accordance with institutional guide-
lines.costimulatory molecules inanti-tumor immunity (Cavallo
et al., 1995; Wu et al., 1995). In light of the present
NK Cell–Mediated Cytotoxicitydata, we speculate that target cells transfected with Two different protocols for activation of NK cells were used. For
costimulatory molecules may, at least in part, be de- activation of NK cells by interleukin-2 (IL-2), 25 3 106 spleen cells
stroyed by NK cells. Cellular debris from tumor cells were resuspended in 10 ml of complete medium (aMEM, 10 mM
HEPES, 2 3 1027 M 2-mercaptoethanol, 10% FCS; all reagents fromdestroyed by NK cells could be processed by profes-
GIBCO Laboratories, Uxbridge, UK) and 1000 U/ml rIL-2 and cul-sional APC, which will then present tumor antigen on
tured in 25 cm2 tissue culture flasks in 10% CO2 at 378C. TheseMHC molecules. This event would in turn activate naive
effector cells are referred to as LAK cells. After 4 days, nonadherent
T cells, leading to the anti-tumor specific responses. and adherent cells were removed, washed once, and resuspended
There have been previous observations regarding the in complete medium without rIL-2 and then used as effectors. In
antibody blocking studies with anti-CD28 or anti-CTLA-4 antibodies,ability of NK cells to interfere with lymphocyte prolifera-
effectors were preincubated with 50 mg, 10 mg, 2 mg, and 0.4 mg oftion in mixed lymphocyte cultures. In those studies, it
antibody for 30 min at room temperature or at 378C before thewas speculated that NK cells might exert this mecha-
cytotoxicity assay. For blocking with CTLA-4Ig, 20 mg/ml was added
nism of action by interfering with APC such as dendritic to target cells for 30 min at room temperature or at 378C before the
cells (Gilbertson et al., 1986). The present findings indi- cytotoxicity assay. For both of these blocking studies, antibodies
and the fusion protein were present during the cytotoxicity assay.cate, but do not prove, a role for NK cells in the control
For isolation of NK1.11, CD81, TCRab1, Ly-49A, and Ly-49C singleof immune responses involving activated APC. We have
or double positive effectors, rIL-2-activated splenocytes culturedshown that autologous bone marrow–derived APC can
for 4 days (see above) were labeled for flow cytometry. Sorting of
efficiently be lysed by NK cells. This event could control cells was performed on a FACS Vantage cell sorter (Becton Dickin-
macrophages or dendritic cells in their stimulation of son, Mountain View, CA). Sorted cells were cultured in IL-2-con-
taining complete medium for 1 additional day to dissociate the anti-naive T cells in lymphoid organs or ensure that these
bodies employed for sorting and then used as effectors. Forcells do not end up in the periphery and cause inflamma-
activation of NK cells with the interferon inducer Tilorone (T-8014)tory or other unwanted responses. Further studies may
(Sigma, St. Louis, MO), 0.2 ml of a 10 mg/ml solution of Tilorone
provide insights into the physiological role of NK cell– was given per os 24 hr before sacrifice and removal of the spleen.
mediated triggering by costimulatory molecules such Single cell suspensions of splenocytes depleted from erythrocytes
as B7-1 and NK cell interaction with APC. by osmotic lysis were used as effector cells. All cytotoxicity studies
were performed in standard 4 hr 51Cr release assays.
Experimental Procedures Generation of Bone Marrow–Derived Macrophages
and Dendritic Cells
Cell Lines and Antibodies Bone marrow–derived macrophages from B6 mice (unless stated
EL-4 is a benzpyrene-induced T cell lymphoma of C57BL/6 (B6) otherwise) were expanded in L-cell supernatants as described pre-
viously (Racoosin and Swanson, 1989). After 8–10 days in culture,origin. C4.4-252 is an MHC class I–deficient (b2-microglobulin2
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these cells were used as targets in a standard 51Cr release assay. numbers of dendritic cells from mouse bone marrow cultures sup-
plemented with granulocyte/macrophage colony stimulating factor.Resting macrophages were obtained by flushing the peritoneal cav-
ity of B6 mice. The erythrocytes were lysed by osmotic shock, and J. Exp. Med. 176, 1693–1702.
the remaining cells were incubated for 1 hr at 378C in plastic dishes. Ka¨gi, D., Lederman, B., Bu¨rki, K., Seiler, P., Odermatt, B., Olsen,
The nonadherent cells were removed, and the remaining adherent K.J., Podack, E.R., Zinkernagel, R.M., and Hengartner, H. (1994).
cells were harvested and used as macrophages. Bone marrow– Cytotoxicity mediated by T cells and natural killer cells is greatly
derived dendritic cells were obtained from B6 mice (unless stated impaired in perforin-deficient mice. Nature 369, 31–37.
otherwise) using the protocol of Inaba et al. (1992) with the following
Karlhofer, F.M., Ribaudo, R.K., and Yokoyama, W.M. (1992). MHC
alterations. Bone marrow cells were cultured in Dulbecco’s modified
class I alloantigen specificity of Ly-491 IL-2-activated natural killer
Eagle’s medium containing 10% supernatant from the GM-CSF-
cells. Nature 358, 66–70.
secreting cell line X63 (a gift from Dr. C. Watts, University of Dundee,
Ka¨rre, K. (1995). Express yourself or die: peptides, MHC moleculesDundee, UK) and 20% FCS. The culture medium was replaced every
and NK cells. Science 267, 978–979.third day, and the cells were replated on day 7. On day 8, the
Ka¨rre, K., Ljunggren, H.G., Piontek, G., and Kiessling, R. (1986).nonadherent cells were used as targets in a standard 4 hr 51Cr
Selective rejection of H-2 deficient lymphoma variants suggestsrelease assay.
alternative immune defence strategy. Nature 319, 675–678.
Koller, B.H., Marrack, P.H., Kappler, J.W., and Smithies, O. (1990).Generation of ConA-Activated T Cell Blasts
Normal development of mice deficient in b2m, MHC class I proteins,For the generation of ConA-activated T cell blasts, 107 spleen cells
and CD81 T cells. Science 248, 1227–1230.depleted from erythrocytes were cultured in RPMI 1640 supple-
mented with 10% FCS and 1.5 mg/ml ConA (Sigma) for 48 hr and Lanier, L.L., and Philips, J.H. (1996). Inhibitory MHC class I receptors
then used as targets in a standard 4 hr 51Cr release assay. on NK cells and T cells. Immunol. Today 17, 86–91.
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